Correvio Pharma Corp. Cash and Cash Equivalents
Correvio Pharma Corp. had Cash and Cash Equivalents of $13.30 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2020-04-30
- 2019-12-31: Cash and Cash Equivalents, at Carrying Value $13.30M.
- 2018-12-31: Cash and Cash Equivalents, at Carrying Value $15.60M.
- 2017-12-31: Cash and Cash Equivalents, at Carrying Value $22.08M.
- 2016-12-31: Cash and Cash Equivalents, at Carrying Value $26.76M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2019-12-31 | $13.30M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $15.60M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $22.08M 40-F · filed 2019-03-13 | |
| 2016-12-31 | $26.76M 20-F · filed 2018-04-30 | |
| 2015-12-31 | $17.66M 20-F · filed 2018-04-30 | |
| 2014-12-31 | $12.71M 20-F · filed 2018-04-30 | |
| 2013-12-31 | $10.98M 40-F · filed 2016-03-29 | |
| 2012-12-31 | $41.00M 40-F · filed 2015-03-27 | $41.27M 20-F/A · filed 2013-04-18 |
| 2011-12-31 | $48.22M 40-F/A · filed 2014-04-30 | $48.64M 40-F/A · filed 2012-04-25 |
| 2010-12-31 | $76.89M 20-F/A · filed 2013-04-18 | |
| 2009-12-31 | $47.27M 20-F/A · filed 2013-04-18 |